Delivra Health Stock Soars On Q3 FY23 Positive Adjusted EBITDA, Here Are The Details
Portfolio Pulse from Vuk Zdinjak
Delivra Health Brands Inc. (DHBUF) reported Q3 FY23 net revenue of $1.7 million, maintaining the same level as last year, with a gross profit of CA$961,000 and an adjusted EBITDA of CA$23,000. The company's stock soared following the announcement.

May 23, 2023 | 2:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Delivra Health's Q3 FY23 results show net revenue of $1.7 million, gross profit of CA$961,000, and positive adjusted EBITDA of CA$23,000, causing the stock to soar.
Delivra Health's Q3 FY23 results show a positive adjusted EBITDA, which indicates the company's profitability. This is a significant improvement compared to the negative adjusted EBITDA in Q3 2022. The positive financial results are likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100